Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksADAM.L Regulatory News (ADAM)

  • There is currently no data for ADAM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Adamas Named Best Asia Pacific Lender

2 Mar 2015 07:00

RNS Number : 1741G
Adamas Finance Asia Limited
02 March 2015
 



 

ADAMAS FINANCE ASIA LIMITED

 

ADAMAS NAMED BEST ASIA PACIFIC LENDER

 

 

Adamas Finance Asia Ltd ("ADAM" or "the Company") announces that its Hong Kong-based investment manager, Adamas Asset Management ("Adamas") has beaten major international competition to be named Best Asia Pacific Lender in the prestigious Private Debt Investor Annual Awards for 2014.

 

Adamas, which has US$620 million under management, saw off close challenges from investment giants, KKR Asset Management and Piramal Fund Management to secure the award.

 

Over the past five years, Adamas has generated consistent gross internal rates of return typically averaging around 30% by providing structured loans to well-managed Chinese SMEs.

The firm mitigates the risks of fraud, corruption, weak contractual enforcement and legal ambiguity sometimes associated with Chinese investment by conducting stringent due diligence, securing a hold over recoverable collateral, and applying detailed attention to loan documentation and preparation for possible legal enforcement.

Since 2010, the Adamas team has experience in providing short-term credit funding to 54 SMEs within China, successfully exiting from 42, and experiencing only five delays in repayments of principal or interest. In each of the five cases, it commenced proceedings in the Chinese courts, with the result that all five defaulters subsequently settled in full either ahead of court action or as a result of judicial decisions.

 

ADAM's exposure to the investment opportunities identified by Adamas has to date been limited by lack of investment funding yet to be realised from its planned programme of disposals. On 18 December 2014 ADAM announced its first major disposal from its legacy portfolio, agreeing the redemption of its interest in the Chinese pharmaceutical company, Global Pharm Holdings Group Inc, for US$25 million and crystallising a US$2.6 million profit over book value.

 

ADAM Chairman, John Croft said: "At a time when there have been well documented issues with certain Chinese companies quoted in London and on other markets, the achievement by Adamas in beating the likes of KKR to be named Best Asia Pacific Lender demonstrates how it is possible with a carefully structured approach to generate attractive and consistent returns from quality Chinese credit-funding deals."

 

He added: "Following the agreement for the redemption of our first legacy investment in December we are now looking forward to participating more actively in projects identified by the Adamas teams, and generating returns for shareholders."

 

 

 

Enquiries:

 

Adamas Finance Asia Limited

John Croft

+44 (0) 1825 830587

Nominated Adviser and Joint Broker

W H Ireland Limited

Tim Feather/Liam Gribben

+44 (0) 113 394 6600

Joint Broker

NSBO

Laurie Pinto

+44 (0) 20 7024 4600

Public Relations Advisers

First City Public Relations (Hong Kong)

Allan Piper

+852 2854 2666

Tavistock Communications (London)

Simon Hudson

+44 (0) 20 7920 3170

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADGGDXDGGBGUB
Date   Source Headline
4th Jul 20137:00 amRNSCo-investment plan with Adamas
28th Jun 201310:36 amRNSAnnual Report and Notice of AGM
27th Jun 20134:44 pmRNSFinal Results
24th Jun 20135:25 pmRNSReduction in Net Asset Value
8th May 20134:40 pmRNSSecond Price Monitoring Extn
8th May 20134:35 pmRNSPrice Monitoring Extension
8th May 20132:41 pmRNSInvestment in Asia Bioenergy Technologies Berhad
7th May 201311:27 amRNSIssue of Equity
29th Apr 201312:03 pmRNSIssue of Equity and Total Voting Rights
15th Apr 20133:45 pmRNSIssue of Equity
5th Mar 20132:13 pmRNSHolding(s) in Company
14th Feb 201310:41 amRNSDirectorate Change
8th Feb 20131:41 pmRNSInvestment in Patimas Computer Berhad
31st Dec 20127:00 amRNSDirector/PDMR Shareholding
24th Dec 201210:34 amRNSDirector/PDMR Shareholding
18th Dec 201211:57 amRNSDirector/PDMR Shareholding
17th Dec 20129:43 amRNSResignation of Director
6th Dec 20127:00 amRNSQuote on Open Market of Frankfurt Stock Exchange
5th Dec 20129:51 amRNSOption Agreement
23rd Nov 20127:00 amRNSDirector/PDMR Shareholding
22nd Nov 20128:00 amRNSStrategic Partnership
15th Oct 20127:00 amRNSRestructuring of Enfinium Investment
4th Oct 201211:58 amRNSPosting of Interim Report
28th Sep 20126:27 pmRNSMr Duncan Chui
26th Sep 201212:36 pmRNSHalf Yearly Report
11th Sep 20124:40 pmRNSSecond Price Monitoring Extn
11th Sep 20124:35 pmRNSPrice Monitoring Extension
28th Aug 20121:23 pmRNSMr Duncan Chui
22nd Aug 20124:40 pmRNSSecond Price Monitoring Extn
22nd Aug 20124:38 pmRNSPrice Monitoring Extension
30th Jul 201210:40 amRNSAGM Statement
16th Jul 20124:18 pmRNSUnusual Share Price Movements
28th Jun 201212:03 pmRNSNotice of AGM and Posting of Annual Report
22nd Jun 20121:11 pmRNSFinal Results
15th Jun 201211:45 amRNSNotice of Results & NAV Update
28th May 201210:41 amRNSKey Strategic co-operation deal with China's Hunan
28th Feb 20127:00 amRNSChange of Adviser
9th Jan 20122:05 pmRNSDirectorate Change
21st Dec 201112:38 pmRNSAppointment of Chief Financial Officer
21st Dec 201112:34 pmRNSIssue of Equity
21st Nov 20114:37 pmRNSDirector/PDMR Shareholding
23rd Sep 201110:51 amRNSHalf Yearly Report
15th Jul 201112:35 pmRNSAGM Statement
22nd Jun 20117:00 amRNSNotice of AGM
8th Jun 20117:00 amRNSFinal Results
7th Jun 20115:13 pmRNSHolding(s) in Company - Replacement
7th Jun 201112:14 pmRNSHolding(s) in Company
24th May 20117:00 amRNSTrading Statement
24th May 20117:00 amRNSNotice of Results & Trading Update
5th May 201111:21 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.